Bi Jingquan, former head of the now-defunct China Food and Drug Administration (CFDA), is being investigated for suspected corruption, China's anti-graft watchdog said on Thursday. Bi, a member of the ...

Beijing is investigating Bi Jingquan, a deputy chief of the economic affairs committee under China’s top political advisory body, for alleged law violations, according to a Thursday statement from the ...

NextCure gains global rights to SIM0505 excluding greater China, where Simcere Zaiming will retain rights; Phase 1 clinical ...

Peninsula Daily News relies on subscription revenue to provide local content for our readers.

The second Trump administration may soon reverse a long-standing pillar of U.S. trade policy -- one that the first Trump ...

China’s National Medical Products Administration (NMPA) has conditionally approved Zymeworks’ zanidatamab for biliary tract cancer (BTC).

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced that the National Medical Products Administration (NMPA) ...

BEIJING, May 29 (Reuters) - Bi Jingquan, former head of the now-defunct China Food and Drug Administration (CFDA), is being investigated for suspected corruption, China's anti-graft watchdog said ...